Exhaled Biomarkers 2010
DOI: 10.1183/1025448x.00028509
|View full text |Cite
|
Sign up to set email alerts
|

Basic aspects of exhaled nitric oxide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
141
0
4

Year Published

2011
2011
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 106 publications
(151 citation statements)
references
References 0 publications
6
141
0
4
Order By: Relevance
“…However, only moderate correlations have been reported between the 2 components, 8 and this view is now being challenged by a model in which systemic inflammation plays an independent role in patients with asthma and other respiratory diseases. 3,9,10 This new hypothesis is supported by data from studies showing that systemic inflammation is not always reduced by inhaled corticosteroids 11,12 and that systemic therapies, such as leukotriene receptor antagonists, might be more effective in reducing systemic inflammatory markers. 13,14 Furthermore, biological treatments directed at blocking IL-5 effectively decrease the signs of systemic inflammation, as measured by B-Eos values, but does not change FENO values, 15 whereas anti-IL-13 treatment reduces FENO values without decreasing B-Eos values.…”
supporting
confidence: 56%
See 2 more Smart Citations
“…However, only moderate correlations have been reported between the 2 components, 8 and this view is now being challenged by a model in which systemic inflammation plays an independent role in patients with asthma and other respiratory diseases. 3,9,10 This new hypothesis is supported by data from studies showing that systemic inflammation is not always reduced by inhaled corticosteroids 11,12 and that systemic therapies, such as leukotriene receptor antagonists, might be more effective in reducing systemic inflammatory markers. 13,14 Furthermore, biological treatments directed at blocking IL-5 effectively decrease the signs of systemic inflammation, as measured by B-Eos values, but does not change FENO values, 15 whereas anti-IL-13 treatment reduces FENO values without decreasing B-Eos values.…”
supporting
confidence: 56%
“…27 FENO signals local IL-4/IL-13-mediated mechanisms in the bronchial mucosa that are primarily triggered by aeroallergen exposure. 3 An increase in FENO values seems to precede moderate, but not severe, asthma exacerbations. 28 We have recently reported that guiding anti-inflammatory treatment in asthma based on FENO measurement resulted in a reduction of moderate, but not severe, exacerbations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the mechanism for the age dependence of FeNO is largely unknown, having the same fixed expiratory flow in all ages is a possible reason [4]. With increasing height accompanying ageing, the total airway mucosal surface area available for NO diffusion will increase, which will lead to higher FeNO levels using the same exhalation flow rate [27,28]. The age-dependence of FeNO has been suggested in previous smaller studies in children [7,[29][30][31]. )…”
Section: Exhaled Biomarkers T-c Yao Et Almentioning
confidence: 93%
“…Estes resultados são consonantes com o que foi referido em The European Respiratory Monograph por Alving e Malinovschi. 57 Relativamente à Fig. 3, uma possível justificação para algumas crianças classificadas pela GINA como parcialmente controlada ou não controlada e que, com base na classificação do FENO, se encontram no nível normal, será devido ao facto do FENO não apresentar uma boa correlação com a inflamação mediada por neutrófilos.…”
Section: Discussionunclassified